Navigation Links
Raptor Pharmaceutical Corp. Announces Closing of $7.5 Million Registered Direct Offering
Date:12/23/2009

p with the Company's process; that Raptor's patents are not sufficient to protect essential aspects of its technology; that competitors may invent better technology; and that Raptor's products may not work as well as hoped or worse, that the Company's products may harm recipients. As well, Raptor's products may never develop into useful products and even if they do, they may not be approved for sale to the public. Raptor cautions readers not to place undue reliance on any such forward-looking statements, which speak only as of the date they were made. Certain of these risks, uncertainties, and other factors are described in greater detail in the Company's filings from time to time with the Securities and Exchange Commission (the "SEC"), which Raptor strongly urges you to read and consider, including Raptor's current report on Form 8-K as filed with the SEC on November 17, 2009; the joint proxy statement/prospectus on Form S-4 filed with the SEC on August 19, 2009; Raptor's annual report on Form 10-K filed with the SEC on March 27, 2009; and Raptor's quarterly report on Form 10-Q filed with the SEC on August 11, 2009, all of which are available free of charge on the SEC's web site at http://www.sec.gov. Subsequent written and oral forward-looking statements attributable to Raptor or to persons acting on its behalf are expressly qualified in their entirety by the cautionary statements set forth in Raptor's reports filed with the SEC. Raptor expressly disclaims any intent or obligation to update any forward-looking statements.


    For more information, please contact:

    Kim R. Tsuchimoto, CFO
    (415) 382-1390
    ktsuchimoto@raptorpharma.com

    The Ruth Group

    Sara Ephraim Pellegrino (investors)
    (646) 536-7002
    spellegrino@theruthgroup.com

    Janine McCargo (media)
    (646) 536-7033
    '/>"/>
SOURCE Raptor Pharmaceutical Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Raptor Pharmaceutical Corp. Announces $7.5 Million Securities Offering
2. Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain
3. Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis
4. Raptor Pharmaceutical Corporation Announces Presentation of Data for NGX426, a Novel, Non-Opioid Oral Analgesic, at Neuropathic Pain Conference
5. Merriman Curhan Ford Acted as Financial Advisor to TorreyPines Therapeutics, Inc. in the Completed Merger With Raptor Pharmaceuticals Corp.
6. Raptor Pharmaceutical Expands Board of Directors
7. Raptor Pharmaceuticals Corp. and TorreyPines Complete Merger
8. Raptor Pharmaceuticals Receives Notices of Allowance for Two NeuroTrans(TM) Patent Applications
9. Raptor Pharmaceuticals Appoints Dr. Patrice P. Rioux as Chief Medical Officer
10. Raptor Pharmaceuticals Announces Completion of Patient Enrollment in Phase 2a Clinical Trial in Non-Alcoholic Steatohepatitis (NASH)
11. Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... 28, 2015 The Physician-Patient Alliance for Health ... campaign, " Surviving Your Hospital Stay ." ... deserve! None of these patients went home from hospital," ... Director, PPAHS) referring to the patient stories ... Coalition to Promote Continuous Monitoring of Patients on Opioids ...
(Date:7/28/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/mp95jv/global_hearing ... "Global Hearing Aids Market 2015-2019" report to ... aids market to grow at a CAGR of ... Factors such as changing demographics and high prevalence ... market has witnessed immense technological advances. These factors, ...
(Date:7/28/2015)... Mike Rowe , spokesperson and reality television personality, will ... 2015 ThoughtSpot conference and tradeshow, which runs from ... Nev. Best known for his ... Channel,s, "Dirty Jobs," Mr. Rowe spent a decade traveling across ... whose hard work, sacrifice and value aren,t always recognized. Prior ...
Breaking Medicine Technology:Surviving Your Hospital Stay: Physician-Patient Alliance for Health & Safety Launches Fundraising for Patient Safety 2Global Hearing Aids Market 2015-2019 with G N Store Nord, Sonova Holdings & William Demant Dominating 2Mike Rowe to Address Community Pharmacists at ThoughtSpot 2015 2
... The SCOOTER Store is supporting the Center for Medical Humanities & ... ethics and humanitarian values to future doctors and health professionals will encourage ... , , ... an opportunity for every American senior to live their entire life safely ...
... May 21 Bayer HealthCare Pharmaceuticals, Inc. today ... a multicenter, open-label Phase 3 study to determine the safety ... patients referred for contrast-enhanced MRI of the central nervous system ... of Neuroradiology (ASNR) in Boston, MA.  The results ...
Cached Medicine Technology:The SCOOTER Store Invests in Ethics Training for Future Doctors 2The SCOOTER Store Invests in Ethics Training for Future Doctors 3Bayer HealthCare Pharmaceuticals, Inc. Announces Results of a Phase 3 Clinical Trial of Gadobutrol 2Bayer HealthCare Pharmaceuticals, Inc. Announces Results of a Phase 3 Clinical Trial of Gadobutrol 3Bayer HealthCare Pharmaceuticals, Inc. Announces Results of a Phase 3 Clinical Trial of Gadobutrol 4
(Date:7/29/2015)... , ... July 29, 2015 , ... Several years ago, ... of children with autism, Little City took a proactive stance and began planning the ... Coleman Foundation grant provides valuable support to building the third home. , “We are ...
(Date:7/29/2015)... Arizona (PRWEB) , ... July 29, 2015 , ... ... dorms. The project, which will by the end will cost the 501(c) organization nearly ... of Arizona’s recent anti-ligature requirements. , “We took it down to the studs,” ...
(Date:7/29/2015)... ... July 29, 2015 , ... People that are passionate about gardening ... on Mercola.com: a vertical “garden tower” and enhanced mineral product for growing ideal crops. ... corners on a porch, balcony, or rooftop – can hold up to 100 plants ...
(Date:7/29/2015)... ... , ... Hernia repairs have always been common and routine surgical procedures and ... National Center for Health Statistics indicates that more than five million Americans currently suffer ... the only effective treatment for a hernia is surgery, only about 750,000 Americans will ...
(Date:7/28/2015)... Church, VA (PRWEB) , ... July 29, 2015 , ... ... Webinar**, Aug. 18, 2015 — 1:30 p.m. – 3:00 p.m. EDT, http://www.fdanews.com/productpipeline ... what they can — and can’t — say about it is tightly regulated by ...
Breaking Medicine News(10 mins):Health News:Little City Receives $500,000 Matching Grant from The Coleman Foundation 2Health News:Little City Receives $500,000 Matching Grant from The Coleman Foundation 3Health News:The New Foundation AZ Renovates Residential Dorms for Youth in Crisis 2Health News:The New Foundation AZ Renovates Residential Dorms for Youth in Crisis 3Health News:Mercola.com Introduces NEW Garden Tower and Enhanced Mineral Solution for Healthy Plants 2Health News:National Statistics Reflect NCMA General Surgery Physicians Findings: Hernia Patients Who Seek Treatment Promptly are More Likely to Enjoy a Quick Recovery 2Health News:National Statistics Reflect NCMA General Surgery Physicians Findings: Hernia Patients Who Seek Treatment Promptly are More Likely to Enjoy a Quick Recovery 3Health News:FDAnews Announces — Talking About Your Product Pipeline: How FDA and SEC Regulate Life Sciences Communications Webinar, Aug. 19, 2015 2Health News:FDAnews Announces — Talking About Your Product Pipeline: How FDA and SEC Regulate Life Sciences Communications Webinar, Aug. 19, 2015 3Health News:FDAnews Announces — Talking About Your Product Pipeline: How FDA and SEC Regulate Life Sciences Communications Webinar, Aug. 19, 2015 4
... cells (progenitor cells) to treat the damage to cardiac ... Emory University School of Medicine. , The study investigators--Emory ... update their colleagues on its progress at the American ... "This is one of the first trials where patients ...
... Panomics Inc., a,developer of innovative technologies and ... exclusive provider of QuantiGene(R) and,QuantiGene Plex(R) products ... that they have been awarded Frost & ... Company of the Year,Award. Frost & Sullivan, ...
... Home Front Needs of Families with Deployed Service Members ... ... Alliance will,present $20,000 to the Utah National Guard Charitable Trust, to help,support the ... representatives Alice Demarais, market vice president for the,mountain region, and Tom Eurek, service ...
... flexibility and if employees perceive that flexibility as real, ... those employees, according to new research by lead author ... of Medicine., The study, titled The Effects of Workplace ... is published in the Dec. 11 issue of The ...
... 10 Novo Nordisk Inc.,today announced the company has ... infringed patents owned by Novo Nordisk.,The patents cover inhaled ... filed in August 2006 in United States,Federal Court in ... is a healthcare company with an 84-year history of,innovation ...
... presented today at the,American Society of Hematology (ASH) ... use of erythropoiesis-stimulating agents (ESAs),for chemotherapy-induced anemia (CIA) ... blood supply. Using a modeling simulation,technique that allowed ... use,findings suggested that even at the lowest reduction ...
Cached Medicine News:Health News:Adult stem cell heart attack study updated at American Society for Hematology Meeting 2Health News:Panomics Inc.: Recipient of the Frost & Sullivan 2007 United States Drug Discovery Technologies Entrepreneurial Company of the Year Award 2Health News:Panomics Inc.: Recipient of the Frost & Sullivan 2007 United States Drug Discovery Technologies Entrepreneurial Company of the Year Award 3Health News:TriWest Contributes $20,000 to Utah National Guard 2Health News:Employees with workplace flexibility have healthier lifestyle habits 2Health News:Modeling Simulation Predicts Potential Negative Impact on U.S. Blood Supply if ESA Use Limited for Chemotherapy-Induced Anemia 2Health News:Modeling Simulation Predicts Potential Negative Impact on U.S. Blood Supply if ESA Use Limited for Chemotherapy-Induced Anemia 3Health News:Modeling Simulation Predicts Potential Negative Impact on U.S. Blood Supply if ESA Use Limited for Chemotherapy-Induced Anemia 4Health News:Modeling Simulation Predicts Potential Negative Impact on U.S. Blood Supply if ESA Use Limited for Chemotherapy-Induced Anemia 5Health News:Modeling Simulation Predicts Potential Negative Impact on U.S. Blood Supply if ESA Use Limited for Chemotherapy-Induced Anemia 6
... Millex Filter Units,Filter units with hydrophobic ... Fluoropore membrane are ideal for the ... of sterile containers, and for sterilizing ... 25 mm Millex filter units are ...
The incorporation of a reverse osmosis (RO) system and an ultrapure water system into a single stand-alone tower provides numerous benefits to the busy laboratory....
... systems produce ultrapure water from pre-treated water at ... to meet the basic needs of scientific laboratories. ... lamp (185 nm and 254 nm) to produce ... 5 ppb TOC when fed by Elix water). ...
... UniBloc weighing mechanism for speed, ... stability control, analog display modes, multiple ... percent measure functions, auto print, and ... data from built-in clock. Built-in, ...
Medicine Products: